Our October newsletter features our upcoming webinar with Dr Sharon Gardiner and our new menopause resource hub. It also highlights our resources coming soon.
From The Team
Our September newsletter introduces our new youth mental health article, EPiC Opioids, and webinar recording. It also highlights the recent updates that we've made to our EPiC Reflect activities.
Medicine access inequity hides in plain sight. Book a free EPiC training session to look more closely at your team's prescribing. Our trainers will take you on a guided tour of the dashboard, explaining how to use the features of EPiC to interpret your data and reflect on your practice.
Our August newsletter highlights our new article on appropriate supply of medicines, our upcoming menopause webinar and our updated EPiC Reflect activity.
Our July newsletter highlights our youth mental health webinar recording and article, our newly translated Virus Action Plans (now available in 7 languages), and the updates to EPiC Annual Report.
The number of youth receiving medicine for emotional and mental health in Aotearoa New Zealand has increased relative to previous years. Perhaps even more concerning, is the widening of the gap in prescribing to rangatahi Māori and young Pacific peoples compared to their peers of European/Other ethnicity.
Find out more in this press release.
Our June newsletter features our youth mental health reflection activity and our upcoming webinar with Drs Cathy Stephenson and Arran Culver. It also highlights our free EPiC training sessions and resources about immune checkpoint inhibitors, triazolam, and ADHD medicine changes.
Data reviewed by He Ako Hiringa suggest that 70,000 patients were still being dispensed cilazapril as at the end of May 2023. This ACE inhibitor is set to be delisted by the end of the year. Consider changing patients to another medicine now, to ensure a smooth pre-Christmas transition.
Find out more in this press release.
Our May newsletter introduces our CQI Toolkit and Virus Action Plans, two new resources focusing on antimicrobial stewardship. It also highlights the recent changes to phenobarbitone branding and liraglutide funding.
Our April newsletter highlights our new UTI case study and microlearning piece on youth mental health. It also outlines the resources that you can expect to see from us soon.
Take a look at the resources we are working on for delivery before the end of 2023.
If you are a subject matter expert who would like to contribute to our work, please email our education lead, andrea@akohiringa.co.nz
Our March newsletter highlights our new liraglutide algorithm, the recording of our cultural safety webinar, and our latest antimicrobial content.